LAUREN RAMOS: Open Payments
NPI 1255950846 · WEST HARTFORD, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,875 in 104 payments from 13 companies in 2025. Trend: 2023 $1,049 · 2024 $1,354 · 2025 $1,875
Food & beverage: $1,875
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $413 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 21 | $300 |
| Boston Scientific Corporation | 8 | $279 |
| Collegium Pharmaceutical, Inc. | 33 | $248 |
| Azurity Pharmaceuticals, Inc. | 9 | $149 |
| Averitas Pharma Inc. | 4 | $120 |
| Medtronic, Inc. | 3 | $99 |
| SCILEX PHARMACEUTICALS INC. | 3 | $73 |
| Valinor Pharma, LLC | 4 | $67 |
| VERTEX PHARMACEUTICALS INCORPORATED | 2 | $60 |
Products named: RELISTOR, General - Pain Management, XTAMPZA, UBRELVY, HORIZANT, QULIPTA, QUTENZA, BOTOX.
Industry payments across CT — which companies pay providers there.
